Research Conducted at Merck & Company Has Provided New Information about Alcoholic Fatty Liver (A Phase Iia Active-comparator-controlled Study To Evaluate the Efficacy and Safety of Efinopegdutide In Patients With Non-alcoholic Fatty Liver ...)

Source :: Obesity, Fitness & Wellness Week. March 23, 2024, 139
Publication Year :: 2024
Abstract: 2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Current study results on Alcohol-Induced Diseases and Conditions - Alcoholic Fatty Liver [...]

Subjects :: Care and treatment
Complications and side effects
Glucagon
Physical fitness
Type 2 diabetes -- Complications and side effects -- Care and treatment
Medical research
Fatty liver -- Complications and side effects -- Care and treatment
Liver
Semaglutide -- Complications and side effects
Medicine, Experimental

Tools